These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22512545)

  • 21. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis.
    Consoli SM; Rolhion S; Martin C; Ruel K; Cambazard F; Pellet J; Misery L
    Dermatology; 2006; 212(2):128-36. PubMed ID: 16484819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
    Daudén E; Griffiths CE; Ortonne JP; Kragballe K; Molta CT; Robertson D; Pedersen R; Estojak J; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1374-82. PubMed ID: 19563497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and magnitude of anxiety and depression in patients with psoriasis vulgaris.
    Nasreen S; Ahmed I; Effendi S
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):397-400. PubMed ID: 18760060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of moderate to severe psoriasis with systemic immunomodulatory therapies: a 5-year experience from two departments of dermatology of Northern France.
    Staumont-Sallé D; Florin V; Cottencin AC; Chaby G; Delaporte E
    J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):1038-9. PubMed ID: 21812831
    [No Abstract]   [Full Text] [Related]  

  • 28. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
    Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
    J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
    Feldman SR; Gottlieb AB; Bala M; Wu Y; Eisenberg D; Guzzo C; Li S; Dooley LT; Menter A
    Br J Dermatol; 2008 Sep; 159(3):704-10. PubMed ID: 18627375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Therapeutic Evaluation of Patients with Moderate to Severe Psoriasis in Spain: The Secuence Study.
    Hernánz JM; Sánchez-Regaña M; Izu R; Mendiola V; García-Calvo C
    Actas Dermosifiliogr; 2012 Dec; 103(10):897-904. PubMed ID: 22748300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis.
    Hayashi M; Umezawa Y; Fukuchi O; Ito T; Saeki H; Nakagawa H
    J Dermatol; 2014 Nov; 41(11):974-80. PubMed ID: 25346301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate to severe psoriasis: from topical to biological treatment.
    Gardinal I; Ammoury A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1324-6. PubMed ID: 19470061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region.
    García-Diez A; Foraster CF; Sebastián FV; Tudela LL; Llach XB; Fernández GS
    Dermatology; 2008; 216(2):137-51. PubMed ID: 18216476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alexithymia and psoriasis: a case-control study of 53 patients].
    Masmoudi J; Maalej I; Masmoudi A; Rached H; Rebai A; Turki H; Jaoua A
    Encephale; 2009 Feb; 35(1):10-7. PubMed ID: 19250988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.